Survival and Death Strategies in Glioma Cells: Autophagy, Senescence and Apoptosis Triggered by a Single Type of Temozolomide-Induced DNA Damage

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Knizhnik, Anna V ^a   Roos, Wynand P ^a   Nikolova, Teodora ^a   Quiros, Steve ^a   Tomaszowski, Karl Heinz ^a   Christmann, Markus ^a   Kaina, Bernd ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

6 O METHYLGUANINE; ATM PROTEIN; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PROTEIN MSH6; RAD51 PROTEIN; TEMOZOLOMIDE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; AUTOPHAGY; CELL ACTIVATION; CELL AGING; CELL ASSAY; CELL DEATH; CELL FUNCTION; CELL STIMULATION; CELL SURVIVAL; CONTROLLED STUDY; DNA ADDUCT; DNA DAMAGE; DRUG EFFECT; ENZYME LOCALIZATION; FLOW CYTOMETRY; GLIOMA CELL; HOMOLOGOUS RECOMBINATION; MISMATCH REPAIR; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANTINEOPLASTIC AGENTS, ALKYLATING; APOPTOSIS; ATAXIA TELANGIECTASIA MUTATED PROTEINS; AUTOPHAGY; CELL AGING; CELL CYCLE PROTEINS; CELL DEATH; CELL LINE, TUMOR; CELL SURVIVAL; DACARBAZINE; DNA DAMAGE; DNA MISMATCH REPAIR; DNA MODIFICATION METHYLASES; DNA-BINDING PROTEINS; GLIOMA; GUANINE; HOMOLOGOUS RECOMBINATION; HUMANS; PROTEIN-SERINE-THREONINE KINASES; TUMOR SUPPRESSOR PROTEINS;

EID: 84873830422     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055665     Document Type: Article

References (40)

1. Villano JL, Seery TE, Bressler LR, (2009) Temozolomide in malignant gliomas: current use and future targets. Cancer Chemother Pharmacol 64: 647-655.
2. Kaina B, Christmann M, Naumann S, Roos WP, (2007) MGMT: key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents. DNA Repair (Amst) 6: 1079-1099.
3. Branch P, Aquilina G, Bignami M, Karran P, (1993) Defective mismatch binding and a mutator phenotype in cells tolerant to DNA damage. Nature 362: 652-654.
4. Caporali S, Falcinelli S, Starace G, Russo MT, Bonmassar E, et al. (2004) DNA damage induced by temozolomide signals to both ATM and ATR: role of the mismatch repair system. Mol Pharmacol 66: 478-491.
5. Quiros S, Roos WP, Kaina B, (2010) Processing of O6-methylguanine into DNA double-strand breaks requires two rounds of replication whereas apoptosis is also induced in subsequent cell cycles. Cell Cycle 9: 168-178.
6. Ochs K, Kaina B, (2000) Apoptosis induced by DNA damage O6-methylguanine is Bcl-2 and caspase-9/3 regulated and Fas/caspase-8 independent. Cancer Res 60: 5815-5824.
7. Roos WP, Batista LF, Naumann SC, Wick W, Weller M, et al. (2007) Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O6-methylguanine. Oncogene 26: 186-197.
8. Kanzawa T, Germano IM, Komata T, Ito H, Kondo Y, et al. (2004) Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells. Cell Death Differ 11: 448-457.
9. Rodriguez-Rocha H, Garcia-Garcia A, Panayiotidis MI, Franco R, (2011) DNA damage and autophagy. Mutat Res 711: 158-166.
10. Tanida I, (2011) Autophagosome formation and molecular mechanism of autophagy. Antioxid Redox Signal 14: 2201-2214.
11. Eisenberg-Lerner A, Bialik S, Simon HU, Kimchi A, (2009) Life and death partners: apoptosis, autophagy and the cross-talk between them. Cell Death Differ 16: 966-975.
12. Schmitt CA, (2007) Cellular senescence and cancer treatment. Biochim Biophys Acta 1775: 5-20.
13. Gunther W, Pawlak E, Damasceno R, Arnold H, Terzis AJ, (2003) Temozolomide induces apoptosis and senescence in glioma cells cultured as multicellular spheroids. Br J Cancer 88: 463-469.
14. Fu D, Calvo JA, Samson LD, (2012) Balancing repair and tolerance of DNA damage caused by alkylating agents. Nat Rev Cancer 12: 104-120.
15. Kaina B, Ochs K, Grosch S, Fritz G, Lips J, et al. (2001) BER, MGMT, and MMR in defense against alkylation-induced genotoxicity and apoptosis. Prog Nucleic Acid Res Mol Biol 68: 41-54.
16. Quiros S, Roos WP, Kaina B, (2011) Rad51 and BRCA2-New molecular targets for sensitizing glioma cells to alkylating anticancer drugs. PLoS One 6: e27183.
17. Sage JM, Gildemeister OS, Knight KL, (2010) Discovery of a novel function for human Rad51: maintenance of the mitochondrial genome. J Biol Chem 285: 18984-18990.
18. Seglen PO, Gordon PB, (1982) 3-Methyladenine: specific inhibitor of autophagic/lysosomal protein degradation in isolated rat hepatocytes. Proc Natl Acad Sci U S A 79: 1889-1892.
19. Dimri GP, Lee X, Basile G, Acosta M, Scott G, et al. (1995) A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A 92: 9363-9367.
20. Young AR, Narita M, Ferreira M, Kirschner K, Sadaie M, et al. (2009) Autophagy mediates the mitotic senescence transition. Genes Dev 23: 798-803.
21. Baker SD, Wirth M, Statkevich P, Reidenberg P, Alton K, et al. (1999) Absorption, metabolism, and excretion of 14C-temozolomide following oral administration to patients with advanced cancer. Clin Cancer Res 5: 309-317.
22. Hammond LA, Eckardt JR, Baker SD, Eckhardt SG, Dugan M, et al. (1999) Phase I and pharmacokinetic study of temozolomide on a daily-for-5-days schedule in patients with advanced solid malignancies. J Clin Oncol 17: 2604-2613.
23. Kaina B, Ziouta A, Ochs K, Coquerelle T, (1997) Chromosomal instability, reproductive cell death and apoptosis induced by O6-methylguanine in Mex-, Mex+ and methylation-tolerant mismatch repair compromised cells: facts and models. Mutat Res 381: 227-241.
24. Hickman MJ, Samson LD, (1999) Role of DNA mismatch repair and p53 in signaling induction of apoptosis by alkylating agents. Proc Natl Acad Sci U S A 96: 10764-10769.
25. Roos WP, Nikolova T, Quiros S, Naumann SC, Kiedron O, et al. (2009) Brca2/Xrcc2 dependent HR, but not NHEJ, is required for protection against O(6)-methylguanine triggered apoptosis, DSBs and chromosomal aberrations by a process leading to SCEs. DNA Repair (Amst) 8: 72-86.
26. Mojas N, Lopes M, Jiricny J, (2007) Mismatch repair-dependent processing of methylation damage gives rise to persistent single-stranded gaps in newly replicated DNA. Genes Dev 21: 3342-3355.
27. Roos WP, Kaina B, (2012) DNA damage-induced apoptosis: From specific DNA lesions to the DNA damage response and apoptosis. Cancer Lett.
28. Alexander A, Cai SL, Kim J, Nanez A, Sahin M, et al. (2010) ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS. Proc Natl Acad Sci U S A 107: 4153-4158.
29. Lin CJ, Lee CC, Shih YL, Lin TY, Wang SH, et al. (2012) Resveratrol enhances the therapeutic effect of temozolomide against malignant glioma in vitro and in vivo by inhibiting autophagy. Free Radic Biol Med 52: 377-391.
30. Palumbo S, Pirtoli L, Tini P, Cevenini G, Calderaro F, et al. (2012) Different involvement of autophagy in human malignant glioma cell lines undergoing irradiation and Temozolomide combined treatments. J Cell Biochem.
31. Chen LH, Loong CC, Su TL, Lee YJ, Chu PM, et al. (2011) Autophagy inhibition enhances apoptosis triggered by BO-1051, an N-mustard derivative, and involves the ATM signaling pathway. Biochem Pharmacol 81: 594-605.
32. Hirose Y, Berger MS, Pieper RO, (2001) Abrogation of the Chk1-mediated G(2) checkpoint pathway potentiates temozolomide-induced toxicity in a p53-independent manner in human glioblastoma cells. Cancer Res 61: 5843-5849.
33. Patschan S, Chen J, Polotskaia A, Mendelev N, Cheng J, et al. (2008) Lipid mediators of autophagy in stress-induced premature senescence of endothelial cells. Am J Physiol Heart Circ Physiol 294: H1119-1129.
34. Singh K, Matsuyama S, Drazba JA, Almasan A, (2012) Autophagy-dependent senescence in response to DNA damage and chronic apoptotic stress. Autophagy 8: 236-251.
35. White E, Lowe SW, (2009) Eating to exit: autophagy-enabled senescence revealed. Genes Dev 23: 784-787.
36. Hermisson M, Klumpp A, Wick W, Wischhusen J, Nagel G, et al. (2006) O6-methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells. J Neurochem 96: 766-776.
37. Vasilevskaya IA, Rakitina TV, O'Dwyer PJ, (2004) Quantitative effects on c-Jun N-terminal protein kinase signaling determine synergistic interaction of cisplatin and 17-allylamino-17-demethoxygeldanamycin in colon cancer cell lines. Mol Pharmacol 65: 235-243.
38. Naumann SC, Roos WP, Jost E, Belohlavek C, Lennerz V, et al. (2009) Temozolomide- and fotemustine-induced apoptosis in human malignant melanoma cells: response related to MGMT, MMR, DSBs, and p53. Br J Cancer 100: 322-333.
39. Debacq-Chainiaux F, Erusalimsky JD, Campisi J, Toussaint O, (2009) Protocols to detect senescence-associated beta-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo. Nat Protoc 4: 1798-1806.
40. Towbin H, Staehelin T, Gordon J, (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 76: 4350-4354.